Autolus Therapeutics Ltd reported $-71.6M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
AstraZeneca USD 2.51B 573M Jun/2026
Autolus Therapeutics Ltd USD -71.6M 18.73M Mar/2026
Hikma Pharmaceutical USD 164M 45M Dec/2025
Novartis USD 3.26B 108M Jun/2026
Roche Holding CHF 6.87B 1.4B Jun/2026
Silence Therapeutics USD -11.77M 9.19M Dec/2025